Do you know the importance of the Pharmacotherapeutic Monitoring Service with MDS in improving therapeutic outcomes in chronic diseases?
The success of a treatment depends on the active participation of the patient, as well as the coordinated intervention of healthcare professionals to maximise the effectiveness and safety of treatments. Therefore, the role of the pharmacist in the detection, prevention and resolution of Medication Related Problems (MRP) is key.
The Pharmacotherapeutic Monitoring Service (PMS) is a pharmaceutical care service aimed at reducing the risks associated with the use of medicines and improving therapeutic outcomes. Often, the SFT integrates the Personalised Dosage System (PDS), which ensures continuity of care for patients, contributing to improving their quality of life.
SFT and MDS
The MDS is a pharmaceutical service aimed at optimising the appropriate use of medicines by repackaging them in specialised and individualised packaging for each patient. In other words, it ensures that the medicines prescribed by the doctor are taken correctly.
Visit after visit, the MDS Pharmacotherapeutic Monitoring Service contributes to better therapeutic outcomes in relation to adherence. As a result, complications and hospitalisations are reduced, leading to an improvement in quality of life as well as savings in healthcare costs.
Pharmacist-patient relationship
The Pharmacotherapeutic Monitoring Service can identify barriers to adherence and propose solutions focused on the needs of each patient (e.g. use of the MDS). It is therefore very important to build a good pharmacist-patient relationship, based on trust and empathy.
What do patients value in pharmacists?
- Be kind and polite.
- Be empathetic.
- Let him listen.
- Be assertive.
These attributes, in turn, contribute to the active involvement of the patient in the management of his or her disease and, therefore, to improving his or her quality of life.
The empowered patient
Why is patient empowerment important?
An empowered patient is an informed and critically thinking patient. The pharmacist, because of his proximity and knowledge, is responsible for educating patients on the use of medicines through health education programmes.
An empowered patient is able to self-manage their chronic disease, which ensures their involvement and participation, and improved therapeutic outcomes. It has been shown that coping with chronic disease in a healthy way results in an improved quality of life.
SFT is a service of interest to achieve these objectives, as it allows for the reduction of DRPs, the setting of targets for improvement and the evaluation of treatment. It also helps patients to feel more supported and confident in the management of their disease.